195 related articles for article (PubMed ID: 33073719)
1. Clinical features and diagnostic imaging of cholangiolocellular carcinoma compared with other primary liver cancers: a surgical perspective.
Takamura H; Gabata R; Obatake Y; Nakanuma S; Hayashi H; Kozaka K; Sasaki M; Okazaki M; Yamaguchi T; Shimbashi H; Terai S; Okamoto K; Makino I; Kinoshita J; Nakamura K; Miyashita T; Tajima H; Ninomiya I; Fushida S; Kitao A; Kitahara M; Arai K; Yamashita T; Yamashita T; Ikeda H; Satoh Y; Harada K; Kaneko S; Gabata T; Kosaka T; Ohta T
Technol Cancer Res Treat; 2020; 19():1533033820948141. PubMed ID: 33073719
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological, radiologic, and molecular study of 23 combined hepatocellular-cholangiocarcinomas with stem cell features, cholangiolocellular type.
Chen J; He J; Deng M; Wu HY; Shi J; Mao L; Sun Q; Tang M; Fan XS; Qiu YD; Huang Q
Hum Pathol; 2017 Jun; 64():118-127. PubMed ID: 28431889
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
[TBL] [Abstract][Full Text] [Related]
4. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
[TBL] [Abstract][Full Text] [Related]
6. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma.
Sasaki M; Sato H; Kakuda Y; Sato Y; Choi JH; Nakanuma Y
Liver Int; 2015 Mar; 35(3):1024-35. PubMed ID: 24712771
[TBL] [Abstract][Full Text] [Related]
8. [Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases].
Xu J; Zhang C; Qiao A; Xi Y
Zhonghua Bing Li Xue Za Zhi; 2016 Mar; 45(3):175-9. PubMed ID: 26956962
[TBL] [Abstract][Full Text] [Related]
9. Post-resection Prognosis of Combined Hepatocellular Carcinoma-Cholangiocarcinoma According to the 2010 WHO Classification.
Jung DH; Hwang S; Hong SM; Chung YK; Song GW; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Park GC; Lee HC; Lim YS; Yu ES; Lee SG
World J Surg; 2017 May; 41(5):1347-1357. PubMed ID: 27896409
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical and molecular features of cholangiolocellular carcinoma are similar to well-differentiated intrahepatic cholangiocarcinoma.
Balitzer D; Joseph NM; Ferrell L; Shafizadeh N; Jain D; Zhang X; Yeh M; di Tommaso L; Kakar S
Mod Pathol; 2019 Oct; 32(10):1486-1494. PubMed ID: 31186529
[TBL] [Abstract][Full Text] [Related]
11. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
Wang X; Wang W; Ma X; Lu X; Li S; Zeng M; Xu K; Yang C
Eur Radiol; 2020 Oct; 30(10):5337-5347. PubMed ID: 32385649
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic Cholangiolocellular and Cholangiocellular Carcinoma - Differences in the
Takahashi Y; Sato S; Ishitobi H; Nagaoka M; Kobayashi Y; Fukuhara H; Yuki M; Komazawa Y; Kuroda H; Shizuku T
Intern Med; 2017 Nov; 56(22):3027-3031. PubMed ID: 28943569
[TBL] [Abstract][Full Text] [Related]
13. Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors.
Song JY; Lee YN; Kim YS; Kim SG; Jin SJ; Park JM; Choi GS; Chung JC; Lee MH; Cho YH; Choi MH; Kim DC; Choi HJ; Moon JH; Lee SH; Jeong SW; Jang JY; Kim HS; Kim BS
Nucl Med Commun; 2015 Apr; 36(4):319-27. PubMed ID: 25564069
[TBL] [Abstract][Full Text] [Related]
14. Hepatic recurrence of cholangiolocellular carcinoma: report of a case.
Yamamoto M; Takasaki K; Nakano M; Saito A
Hepatogastroenterology; 1996; 43(10):1046-50. PubMed ID: 8884337
[TBL] [Abstract][Full Text] [Related]
15. Post-resection prognosis of combined hepatocellular carcinoma-cholangiocarcinoma cannot be predicted by the 2019 World Health Organization classification.
Kim M; Hwang S; Ahn CS; Kim KH; Moon DB; Song GW; Jung DH; Hong SM
Asian J Surg; 2021 Nov; 44(11):1389-1395. PubMed ID: 33766528
[TBL] [Abstract][Full Text] [Related]
16. Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction.
Sempoux C; Fan C; Singh P; Obeidat K; Roayaie S; Schwartz M; Fiel MI; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):104-10. PubMed ID: 21344355
[TBL] [Abstract][Full Text] [Related]
17. Combined hepatocellular-cholangiocarcinoma with stem cell features, ductal plate malformation subtype: a case report and proposal of a new subtype.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):737-48. PubMed ID: 23573322
[TBL] [Abstract][Full Text] [Related]
18. Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI.
Fowler KJ; Sheybani A; Parker RA; Doherty S; M Brunt E; Chapman WC; Menias CO
AJR Am J Roentgenol; 2013 Aug; 201(2):332-9. PubMed ID: 23883213
[TBL] [Abstract][Full Text] [Related]
19. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Imaging and Clinically Relevant Features of Combined Hepatocellular Carcinoma and Cholangiocarcinoma with Hepatocellular Carcinoma.
Huang X; Li Y; Long L
Med Sci Monit; 2019 Nov; 25():8595-8601. PubMed ID: 31726461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
